STAT3 mutations, predominantly detected in CD8 + T-LGLL patients [3, 6], are associated with the development of a symptomatic disease, mainly characterized by neutropenia and anemia [8, 9], leading to reduced overall survival of patients [6]. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.